JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational[4] pharmaceutical company.[5] It is headquartered in Dolgoprudny, Moscow Oblast.
Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.[citation needed]
Pharmstandard was established in 2003 as a result of a merger.[5]
In May 2007 the company raised $880 million in an IPO, valuing the company at $2.2 billion.[6]Roman Abramovich owned a 17% stake in the company until March 2008.[7]
In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%.[8]
Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.[9][10]
References
^. Expert RA. Archived from the original on 28 October 2018. Retrieved 28 October 2018.
^ abAnatoly, Zhuplev (2014). Geo-Regional Competitiveness in Central and Eastern Europe, the Baltic Countries, and Russia. IGI Global. p. 228. ISBN9781466660557.
^Spikes, Salamander Davoudiand Sarah (5 May 2007). "Russian drug IPO raises $880m". Financial Times. Retrieved 25 September 2017.
^"Russia's Abramovich sells his stake in drug maker". Reuters. 2008. Retrieved 25 September 2017.
^"Pharmstandard to buy ingredient supplier for $590 million". Reuters. 2013. Retrieved 25 September 2017.
^"BRIEF-Pharmstandard shares to be delisted as of March 24 - Moscow Exchange". Reuters. 17 February 2017. Retrieved 23 April 2017.
^"Об исключении ценных бумаг из Списка ценных бумаг, допущенных к торгам, и о прекращении торгов ценными бумагами". Московская Биржа. Retrieved 28 August 2017.
February 10, 2023
pharmstandard, russian, ПАО, Фармстандарт, romanized, farmstandart, russian, multinational, pharmaceutical, company, headquartered, dolgoprudny, moscow, oblast, typeprivateindustrypharmaceuticalsfounded2003headquartersdolgoprudny, russiaarea, servedworldwideke. JSC Pharmstandard Russian PAO Farmstandart romanized PAO Farmstandart is a Russian multinational 4 pharmaceutical company 5 It is headquartered in Dolgoprudny Moscow Oblast JSC PharmstandardTypePrivateIndustryPharmaceuticalsFounded2003HeadquartersDolgoprudny RussiaArea servedWorldwideKey peopleViktor Kharitonin Chairman Igor Krylov CEO ProductsRemediesRevenue 638 million 1 2017 Operating income 231 million 2 2016 Net income 119 million 2 2016 Total assets 1 41 billion 2 2016 Total equity 936 million 2 2016 Number of employees6 450 3 2015 Websitepharmstd comPharmstandard s makes and exports over 400 generic and proprietary drugs including products used in the treatment of diabetes growth hormone deficiency cardiovascular diseases gastroenterological and neurological disorders infectious diseases cancer etc citation needed The company has six manufacturing facilities located in Moscow Ufa Nizhny Novgorod Kursk Tomsk and Tyumen History EditPharmstandard was established in 2003 as a result of a merger 5 In May 2007 the company raised 880 million in an IPO valuing the company at 2 2 billion 6 Roman Abramovich owned a 17 stake in the company until March 2008 7 In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical causing Pharmstandard shares to fall 25 8 Pharmstandard was delisted from the London and Moscow stock exchanges in 2017 9 10 References Edit Rejting krupnejshih kompanij Rossii po obemu realizacii produkcii Expert RA Archived from the original on 28 October 2018 Retrieved 28 October 2018 a b c d http pharmstd com news3files 2016ifrsresults pdf http www rbc ru companies id 126 Pharmstandard International a b Anatoly Zhuplev 2014 Geo Regional Competitiveness in Central and Eastern Europe the Baltic Countries and Russia IGI Global p 228 ISBN 9781466660557 Spikes Salamander Davoudiand Sarah 5 May 2007 Russian drug IPO raises 880m Financial Times Retrieved 25 September 2017 Russia s Abramovich sells his stake in drug maker Reuters 2008 Retrieved 25 September 2017 Pharmstandard to buy ingredient supplier for 590 million Reuters 2013 Retrieved 25 September 2017 BRIEF Pharmstandard shares to be delisted as of March 24 Moscow Exchange Reuters 17 February 2017 Retrieved 23 April 2017 Ob isklyuchenii cennyh bumag iz Spiska cennyh bumag dopushennyh k torgam i o prekrashenii torgov cennymi bumagami Moskovskaya Birzha Retrieved 28 August 2017 Retrieved from https en wikipedia org w index php title Pharmstandard amp oldid 1031423149, wikipedia, wiki, book, books, library,
